[ad_1]
| All information about GAN & LEE PHARMACEUTICALS. |
|
|
|
|
|
|
|
| Gross sales 2022 |
4 002 M
583 M
583 M
|
| Internet earnings 2022 |
1 533 M
223 M
223 M
|
| Internet Debt 2022 |
–
–
–
|
| P/E ratio 2022 |
13,6x |
| Yield 2022 |
– |
|
| Capitalization |
20 872 M
3 043 M
3 043 M
|
| Capi. / Gross sales 2022 |
5,22x |
| Capi. / Gross sales 2023 |
4,31x |
| Nbr of Staff |
3 278 |
| Free-Float |
28,4% |
|
| Chart GAN & LEE PHARMACEUTICALS. |
|
Period :
Interval :
|
 |
|
|
Technical evaluation tendencies GAN & LEE PHARMACEUTICALS.
|
Brief Time period |
Mid-Time period |
Lengthy Time period |
| Tendencies |
Bearish |
Bearish |
Bearish |
Revenue Assertion Evolution
|
|
| Imply consensus |
OUTPERFORM |
| Variety of Analysts |
1 |
| Final Shut Value |
37,17 |
| Common goal worth |
|
| Unfold / Common Goal |
– |
|
[ad_2]
Source link
